Increased prevalence of primary sclerosing cholangitis among first-degree relatives

J Hepatol. 2005 Feb;42(2):252-6. doi: 10.1016/j.jhep.2004.10.011.

Abstract

Background/aims: The aim of the present study was to investigate the familial occurrence of autoimmune diseases in a large group of patients with primary sclerosing cholangitis (PSC).

Methods: All patients with PSC treated at Huddinge University Hospital between 1984 and 1999 were included (n=145). For every patient with PSC and inflammatory bowel disease (IBD) (n=126) we randomly selected a control patient with IBD (n=126), matched for age, sex and type of IBD. A questionnaire comprising information about autoimmune diseases among first-degree relatives was answered by all patients and controls.

Results: We identified 22 index cases with PSC from 21 families with a first-degree relative with either chronic liver disease and/or IBD. Five patients with PSC had a first-degree relative with PSC (3.4%). The prevalence of PSC among first-degree relatives was 0.7% (5/717). In siblings the prevalence was 1.5% (4/269). The prevalence of first-degree relatives with autoimmune diseases outside the liver was similar in PSC patients and controls.

Conclusions: First-degree relatives of patients with PSC have a PSC prevalence of 0.7%. This represents a nearly 100-fold increased risk of developing PSC compared with the general population, supporting the hypothesis that genetic factors are of importance for development of PSC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases / epidemiology
  • Cholangitis, Sclerosing / epidemiology*
  • Cholangitis, Sclerosing / genetics*
  • Family
  • Female
  • Humans
  • Irritable Bowel Syndrome / epidemiology
  • Irritable Bowel Syndrome / genetics
  • Liver Diseases / epidemiology
  • Liver Diseases / genetics
  • Male
  • Nuclear Family
  • Prevalence
  • Surveys and Questionnaires